Evidence map›Paper›PMID 40650812›Full record

ArticleScience China. Life sciences2025

WTAP-mediated m

Huifeng Wang, Die Zhang, Yiqiang Ouyang, Jinwan Li, Guangfu Pang, Xing Xie, Hongli Huang, Tengyue Yan, Xianwu Pang, Qingniao Zhou and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Science China. Life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. WTAP mediated mScience China. Life sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Huifeng Wang *Department of Human Anatomy, School of Basic Medical Sciences, Guangxi Medical University, Nanning, 530021, China.
Die Zhang *Collaborative Innovation Centre of Regenerative Medicine and Medical Bio Resource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, 530021, China.
Yiqiang Ouyang *Laboratory Animal Center, Guangxi Medical University, Nanning, 530021, China.
Jinwan Li *Department of Immunology, Basic Medical College of Guangxi Medical University, Nanning, 530021, China.
Guangfu Pang *Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, 530021, China.
Xing XieInstitute of Life Sciences, Guangxi Medical University, Nanning, 530021, China.
Hongli HuangInstitute of Life Sciences, Guangxi Medical University, Nanning, 530021, China.
Tengyue YanCollaborative Innovation Centre of Regenerative Medicine and Medical Bio Resource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, 530021, China.
Xianwu PangCollaborative Innovation Centre of Regenerative Medicine and Medical Bio Resource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, 530021, China.
Qingniao ZhouDepartment of Biochemistry and Molecular Biology, School of Pre-Clinical Medicine, Guangxi Medical University, Nanning, 530021, China.
Bo XieInstitute of Life Sciences, Guangxi Medical University, Nanning, 530021, China.
Fubo WangCenter for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, 530021, China. wangbofengye@163.com.
Sanqi AnInstitute of Life Sciences, Guangxi Medical University, Nanning, 530021, China. ansq@mail2.sysu.edu.cn.
Yanling HuCenter for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, 530021, China. huyanling@gxmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The specific mechanisms of N

Indexed as

AdenosineProstatic Neoplasms, Castration-ResistantReceptors, Thyroid HormoneRNA Splicing FactorsAnimalsCell Cycle ProteinsCell Line, TumorDrug Resistance, NeoplasmFlutamideGene Expression Regulation, NeoplasticHumansMaleMiceMice, NudeProstatic NeoplasmsReceptors, GlucocorticoidAdenosineCell Cycle ProteinsFlutamideN-methyladenosineNR3C1 protein, humanReceptors, GlucocorticoidReceptors, Thyroid HormoneRNA-Binding ProteinsRNA Splicing FactorsWTAP protein, humanYTHDF2 protein, humanCRPCdrug sensitivitym6ANR3C1WTAPYTHDF2

Identifiers

PMID40650812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.